Company: DMAAR
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-046061
Chunk: 93

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 2
Chunk 93
---

of: (1) our completion of an initial business combination; (2) the redemption of any public shares properly submitted in connection with
a shareholder vote to amend our amended and restated memorandum and articles of association (A) to modify the substance or timing of our
obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we do not
complete our initial business combination within the completion window or (B) with respect to any other material provisions relating to
shareholders’ rights or pre-initial business combination activity; and (3) the redemption of our public shares if we have not completed
an initial business combination within the completion window, subject to applicable law. The funds in the trust account will be invested
only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under
Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations and/or held as cash or cash
items (including in demand deposit accounts).

We will have up to 15 months to consummate an
initial business combination from the closing of the IPO (which may be extended without shareholder approval up to two times, each by
an additional three months (for a total of up to 21 months to complete an initial business combination from the closing of the IPO), subject
to the sponsor depositing into the trust account $0.10 per public share outstanding in connection with each such extension). If we are
unable to consummate an initial business combination within such time period, we will redeem 100% of the issued and outstanding public
shares for a pro rata portion of the funds held in the trust account, equal to the aggregate amount then on deposit in the trust account,
including interest earned on the funds held in the trust account (net of funds withdrawn to pay our taxes, if any, and up to $100,000
of interest to pay dissolution expenses), divided by the number of then issued and outstanding public shares, subject to applicable law,
and then seek to liquidate and subsequently dissolve.

20

We will provide our public shareholders with the
opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the consummation
of the initial business combination,